Charles Theuer, President and CEO at Tracon Pharmaceuticals, Inc. (TCON), bought 50,999 shares at $0.75 ($38K) on 2023-04-27, disclosed to the SEC on 2023-04-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.66 | 3,999 | $3K | 7.0% |
| 2 | $0.75 | 47,000 | $35K | 93.0% |
| Total | $0.74 avg | 50,999 | $38K | 100% |
| Filing → |
| TCON | BUY | 2022-12-15 | $30K | — | Filing → |
| TCON | BUY | 2022-11-22 | $20K | — | Filing → |
| TCON | BUY | 2022-11-04 | $14K | — | Filing → |